Our findings highlight a potentially important disease-modifying functionality for IFN-γ in early arthritis which might signify a rethink with regard to timely intervention with IFN-γ in innovative treatment protocols for inflammatory joint diseases such as RA. This evidence concerns the gene IFNG and arthritic joint disease.